Good governance for clinical commissioning groups: an introductory guide

Posted:09 December 2011
Comments 1 comment

Authors

Candace Imison
Beccy Baird
Katy Steward
Andrew Willis

Written for the NAPC and KPMG, this introductory guide to good governance for clinical commissioning groups aims to help them take their first steps towards authorisation.

Related content

Difficult commissioning decisions: How to navigate changing and challenging times

Future of commissioning

Comments

Having read part of the role/resposibility/targets of the Clinical Commisioning Group i believe it is based on pure cost rather than peoples health and social needs. I believe in reality it will be the accountants that will be controlling the NHS and there will be in the future moves to drive down treatments people need because of it has before under this government and will happen again.

Add your comment

You may also be interested in

Should we be worried about CCG conflicts of interest?

Are conflicts of interest affecting the services patients receive? Or is this inherent feature of clinical commissioning being managed appropriately through common-sense decision-making?

Balancing liberation with accountability?

Anna Dixon looks at the difficulties in setting objectives for the NHS and at how the NHS Commissioning Board can be effectively held accountable for £80 billion of public money.

Brexit

Brexit and the end of the transition period: what does it mean for the health and care system?

On Christmas Eve 2020 a new EU-UK trade and co-operation deal was agreed. Jonathon Holmes looks at what the new deal means for the health and care system.

Community pharmacy explained

Community pharmacy is a critical part of primary care in England, but its role and relationship to the wider NHS is often poorly understood. This explainer looks at the community pharmacy sector in England, explaining how pharmacies are contracted and funded, the types of services they provide and future trends in the sector.